Balyasny Asset Management LLC Heron Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $62,333 - $103,710	26,868 New	26,868 $94,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $590,341 - $1.23 Million	262,374 Added 827.97%	294,063 $735,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $1.26 Million - $2.53 Million	-471,996 Reduced 93.71%	31,689 $133,000
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $1.16 Million - $3.17 Million	503,685 New	503,685 $1.41 Million
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $2.79 Million - $5.99 Million	-602,613 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $1.02 Million - $1.54 Million	121,841 Added 25.34%	602,613 $5.5 Million
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $905,004 - $1.34 Million	89,339 Added 22.82%	480,772 $5.14 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $5.19 Million - $7.23 Million	391,433 New	391,433 $6.08 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $3.25 Million - $5.03 Million	-191,698 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $2 Million - $2.45 Million	86,493 Added 82.21%	191,698 $4.69 Million
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $4.63 Million - $6.73 Million	-210,249 Reduced 66.65%	105,205 $2.73 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $9.46 Million - $12.9 Million	315,454 New	315,454 $9.98 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $43.1 Million - $68.6 Million	-1,632,240 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $43,476 - $67,939	2,359 Added 0.14%	1,632,240 $45.1 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $7.22 Million - $9.2 Million	487,926 Added 42.73%	1,629,881 $29.5 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $16.7 Million - $19.2 Million	1,141,955	1,141,955 $18.4 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$30.5 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$10.1 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.94 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$9.49 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.96 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $135M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account